Molina Healthcare MOH Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| —— | $1.18B+8.1% | $1.09B+37.8% | $792M+20.2% | ||
| $195M+4.8% | $186M+8.8% | $171M-2.8% | $176M+34.4% | ||
| $50M-56.9% | $116M+0.9% | $115M+11.7% | $103M+43.1% | ||
| -$43M— | —— | $33M-50.0% | $66M+175% | ||
| —— | $0— | $0-100% | $208M— | ||
| —— | $115M— | —— | $55M-60.1% | ||
| -$52M-191% | $57M— | —— | $124M— | ||
| -$3M-138% | $8M— | —— | —— | ||
| —— | —— | —— | -$11M— | ||
| -$201M-1,017% | -$18M-800% | -$2M— | —— | ||
| —— | —— | —— | —— | ||
| —— | -$40M— | —— | —— | ||
| -$535M— | —— | —— | —— | ||
| $102M+2.0% | $100M+12.4% | $89M-2.2% | $91M+18.2% | ||
| —— | —— | $3M-97.8% | $134M— | ||
| —— | —— | —— | —— | ||
| $312M— | —— | -$744M— | —— | ||
| —— | $1B— | —— | $400M— | ||
| —— | -$30M-1,600% | $2M— | —— | ||
| —— | —— | —— | -$451M— | ||
| -$417M— | —— | —— | -$458M— | ||
| $181M+49.6% | $121M+12.0% | $108M0.0% | $108M-15.0% | ||
| —— | $0— | $0-100% | $208M— | ||
| -$43M— | —— | $33M-50.0% | $66M+175% | ||
| -$591M-30.5% | -$453M— | —— | -$428M-141% | ||
| -$52M-191% | $57M— | —— | $124M— | ||
| —— | —— | —— | —— | ||
| —— | —— | $60M+11.1% | $54M+1.9% | ||
| —— | -$30M-1,600% | $2M-93.9% | $33M+3,200% | ||
| —— | $300M— | $0— | —— | ||
| -$636M— | —— | —— | —— | ||
| -$636M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Molina Healthcare generate?
- Molina Healthcare (MOH) generated $357.0M in operating cash flow over the trailing twelve months.
- What is Molina Healthcare's free cash flow?
- After $107.0M of capital expenditures, Molina Healthcare's free cash flow was $251.0M over the trailing twelve months, down 73.5% year over year.
- Where does Molina Healthcare's cash flow data come from?
- Every line is extracted from Molina Healthcare's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
